The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| IMCR | +15.32% | -17.73% | -3.83% | -22% |
| S&P | +18.89% | +78.8% | +12.32% | +77% |
Immunocore Holdings Plc operates as a holding company. The company was founded on January 7, 2021 and is headquartered in Abingdon, the United Kingdom.
Immunocore, Axsome Therapeutics, and Takeda are significantly outperforming the market this year.
| Q4 2025 | YOY Change | |
|---|---|---|
| Revenue | $104.33M | 25.3% |
| Gross Profit | $100.80M | 23.2% |
| Gross Margin | 96.61% | -1.6% |
| Market Cap | $1.75B | 18.7% |
| Market Cap / Employee | $3.34M | 0.0% |
| Employees | 524 | 6.3% |
| Net Income | -$30,016.57K | -27.5% |
| EBITDA | -$18,829.75K | -3.9% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q4 2025 | YOY Change | |
|---|---|---|
| Net Cash | $467.71M | 2.6% |
| Accounts Receivable | $73.98M | 17.4% |
| Inventory | 6.7 | 23.8% |
| Q4 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $434.68M | 0.8% |
| Short Term Debt | $2.01M | 29.7% |
| Q4 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -3.43% | 2.9% |
| Return On Invested Capital | -29.46% | 36.4% |
| Q4 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$35,643.96K | -101.4% |
| Operating Free Cash Flow | -$32,759.08K | -132.0% |
| Metric | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | 4.14 | 4.18 | 4.74 | 4.44 | 13.09% |
| Price to Sales | 4.61 | 4.41 | 4.82 | 4.37 | -8.15% |
| Price to Tangible Book Value | 4.12 | 4.16 | 4.71 | 4.42 | 13.09% |
| Price to Free Cash Flow TTM | 70.65 | 59.17 | 55.04 | 640.74 | 717.00% |
| Enterprise Value to EBITDA | -410.56 | -79.32 | -217.06 | -70.32 | 17.02% |
| Free Cash Flow Yield | 1.4% | 1.7% | 1.8% | 0.2% | -87.76% |
| Return on Equity | -5.8% | -5.4% | -7.5% | -9.6% | -31.08% |
| Total Debt | $433.99M | $436.46M | $435.86M | $436.69M | 0.92% |
No podcast episodes available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
